ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Comprehensive Center NCAB Evaluations

June 2, 1978

Breast MRI Recipients More Likely To Choose Mastectomy

July 31, 2009

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

Judge Rules First Amendment Protects Distribution Of Off-Label Use Information

August 14, 1998